Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
News Menu

News

CytoDyn Highlights NIH Grant for HIV Functional Cure Preclinical Study of Gene Therapy Based on Leronlimab

Globe Newswire - Press Release

All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here

$5 Million Grant Awarded to OHSU for Preclinical Research of One-time Injection of Gene Therapy Based on Leronlimab for Functional Cure of HIV

VANCOUVER, Washington, July 11, 2022 (GLOBE NEWSWIRE) --  CytoDyn Inc. (OTC-BB:CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced a new, preclinical study in nonhuman primates that will evaluate the potential use in HIV of a gene therapy based on the experimental monoclonal antibody leronlimab.

Read more at globenewswire.com

Related Symbols

Symbol Last Chg %Chg
CYDY 0.2583 -0.0053 -2.01%
Cytodyn Inc

Most Popular News

Intel Corp_ logo on mobile phone-by Piotr Swat via Shutterstock 1
Intel Stock Just Got a New Street-High Price Target. Should You Buy INTC Here?
An image of a Tesla humanoid robot in front of the company logo Around the World Photos via Shutterstock 2
Dear Tesla Stock Fans, Mark Your Calendars for February 14
Alphabet (Google) Image by Markus Mainka via Shutterstock 3
After an 82% Rally, Can Apple and Walmart Agreements Push Google Stock Higher?
Nvidia logo by Konstantin Savusia via Shutterstock 4
China May Be Blocking H200 Shipments After All. Should You Sell the News for Nvidia Stock?
Credit cards in jeans pocket by TheDigitalWay via Pixabay 5
SoFi CEO Anthony Noto Says His Company Is Poised to Win if Trump Caps Credit Card Rates: Why Personal Loans Could Come Out on Top
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot